LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
02/28/2024
Back to search
Official data from USPTO
I PEACE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
I PEACE
ST13
US500000079339458Class
1, 3, 5, 39, 42, 44
Filing
79339458
Registration
7135012
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
02/28/2024
Trademark type
Word
Nice classes
1, 3, 5, 39, 42, 44
Filing date
09/15/2021
Registration date
08/15/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/15/2023
Last transaction
08/15/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
US
Examiner
CANTONE, KERI
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
I Peace, Inc.
Representatives
M. Scott Alprin Alprin Law Offices, P.C.
Technical classification
Nice Classes
Class 1Class 3Class 5Class 39Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Cell culture media for laboratory useother than for medical or veterinary purposes; microorganism culture media for laboratory useother than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; chemicals used as ingredients for manufacture of cosmetics; chemicals for industrial purposes; culture fluid for human stem cell as an ingredient for cosmetics manufacturing; stem cells for research and scientific purposes; cell culture media for scientific or research purposes
Class 3
Cosmetics containing culture fluid for human stem cell; cosmetics; bath and cosmetic soaps and laundry and dishwasher detergents; dentifrices; perfumery
Class 5
Stem cells for medical purposes; stem cells for clinical medical purposes; stem cells for veterinary purposes; diagnostic media for bacteriological cultures; cell culture media for microorganism culture for medical use; cell culture for medical use; pharmaceutical preparations for human use derived from iPS cells for treating neural diseasemuscular diseaseheart diseaseskin diseaseautoimmune diseasekidney diseaseeye diseasediabetesmetabolic liver diseasecancersblood diseasesreproductive organ diseaseslung diseaseear and throat diseaseinfectious diseasedigestive disease and joint disease; pharmaceutical preparations for human use developed by using iPS cells for treating neural diseasemuscular diseaseheart diseaseskin diseaseautoimmune diseasekidney diseaseeye diseasediabetesmetabolic liver diseasecancersblood diseasesreproductive organ diseaseslung diseaseear and throat diseaseinfectious diseasedigestive disease and joint disease; dietary supplements; dietetic preparations adapted for medical purposes
Class 39
Storage of stem cell and cells; warehousing services for deposited frozen stem cell and cells; consultancy and information relating to warehousing services for deposited frozen stem cell and cells; warehousing services
Class 42
Cell culture services for scientific and research purposes for others; providing scientific information related to cell culture; cytogenetic examination being cytogenic research services for others; testing examinationresearch and development in the field of regenerative medicine; testingexaminationresearch and development in the field of cytology; testingexaminationresearch and development of cosmetics; medical laboratory services; research in the field of pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; conducting clinical trials for pharmaceuticals
Class 44
Stem cell bank services; medical treatment services by using cultured cells; stem cell therapy services; collection and preservation of stem cells for use in regenerative medicine; collection and preservation of human blood; providing medical information in the field of cells; providing medical information related to regenerative medicine; provision of medical information; medical treatment and diagnosis services by using cultured cells for medical and clinical purposes; medical services; providing information and data for medical diagnosis and treatment; medical treatment and diagnosis by regenerative medicine; medical treatment and diagnosis services by cell therapy; medical treatment and consulting services by cell preparations; medical treatment of speech disordersbreast cancer and infertilityneural diseasemuscular diseaseheart diseaseskin diseaseautoimmune diseasekidney diseaseeye diseasediabetesmetabolic liver diseasecancersblood diseasesreproductive organ diseaseslung diseaseear and throat diseaseinfectious diseasedigestive disease and joint diseasenot limited to stem cells; preservation of human blood as a supply source of stem cells; clinical medical examination; evaluation of clinical examination for medical purposes; genetic testing for medical purposes; providing medical facilities; Health clinic services; providing health information; dietary and nutritional guidance; rental of medical machines and apparatus
Publications
History of USPTO decisions and trademark events.
34 publications found
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
01/01/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/11/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/16/2023
FIMP
FINAL DISPOSITION PROCESSED
11/15/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/15/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/15/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/15/2023
GPNX
NOTIFICATION PROCESSED BY IB
05/30/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/30/2023
PUBO
PUBLISHED FOR OPPOSITION
05/30/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/10/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/25/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
04/25/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/25/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
04/25/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/25/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/09/2023
GNFR
FINAL REFUSAL E-MAILED
01/09/2023
CNFR
FINAL REFUSAL WRITTEN
01/09/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
12/27/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
12/27/2022
RFNT
REFUSAL PROCESSED BY IB
08/17/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/26/2022
RFRR
REFUSAL PROCESSED BY MPU
07/26/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/28/2022
CNRT
NON-FINAL ACTION WRITTEN
06/27/2022
DOCK
ASSIGNED TO EXAMINER
06/19/2022
MAFR
APPLICATION FILING RECEIPT MAILED
05/17/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/13/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/10/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/28/2022
Continuous trademark protection
Get notified about every new filing that threatens I PEACE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.